Generic Peptides Expands U.S. Supply and Batch Transparency Initiative
Expanded batch documentation and product information give research buyers additional access to laboratory material records before ordering
NEW YORK, NY, August 24, 2026 — Generic Peptides, a U.S.-based supplier of research peptides and laboratory compounds, today announced an expansion of its U.S. supply and batch transparency initiative, including broader presentation of available Certificates of Analysis and additional product documentation across relevant product pages.
The update is intended to give research buyers more information about laboratory materials before procurement. Where documentation is available, individual product pages may include batch-specific analytical information such as reported purity, measured content, analysis dates and supporting laboratory records.
Certific...
